A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide
Year: 2013
Type: article
Source: The Journal of Immunology
Authors: Qiong Luo, Yang Sun, Wen Liu, Cheng Qian, Biao Jin, Feifei Tao, Yanhong Gu, Xingxin Wu, Yan Shen, Qiang Xu
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2144635371
